I received a BSc in Biochemistry (2001, University of Barcelona) and Ph.D. in Immunology (2006, IRB-PCB-UB). My research was focused on innate immunity during inflammation studying the signaling pathways involved in proliferation, differentiation and apoptosis, including KRAS/ BRAF/MAPK, PI3K. We developed new nanotechnology strategies to activate the immune system and regulate inflammatory responses. I have been a postdoc in CRG (Center for Genomic Regulation, Barcelona) and invited scientist at the AECOM (NY) developing hematopoietic reprogramming.

In 2007, I joined IDIBAPS studying hematological and colorectal cancers and translational research using cellular and transgenic models. I focused on Wnt pathway regulating epithelial-mesenchymal transition and mechanisms involved in invasion and stroma remodeling, tumor invasiveness and metastasis as well as senescence and chemoresistance.

Currently, I’m a Miguel Servet researcher and my interest includes the study of transcriptional and post-translational mechanisms that promote proliferation and progression of colorectal cancer associated with oncogene (KRAS, BRAF)/tumor suppressor (APC) mutations. My aim is gaining of in-depth knowledge of the mechanisms involved in the development and progression of CRC premalignant and malignant lesions, including transcriptional regulation, proteasome degradation, metabolism deregulation and epithelial-tumor interaction with a view to defining new diagnostic, therapeutic and/or preventive strategies.